Migraine Clinical Trials in Austin, Texas

6 studies are recruiting for migraine in Austin, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   FutureSearch Trials of Neurology, Austin, Texas

   Locations

   113 in total

   Run by

   TriGemX Bio, Inc.

   See if you can join NCT07645924 on ClinicalTrials.gov

2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Central Texas Clinical Research, Austin, Texas

   Locations

   72 in total

   Run by

   TriGemX Bio, Inc.

   See if you can join NCT07816367 on ClinicalTrials.gov

3. Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

   This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study. Neither partic…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   FutureSearch Trials of Neurology, Austin, Texas

   Locations

   20 in total

   Run by

   Aspeya, Inc.

   See if you can join NCT07646613 on ClinicalTrials.gov

4. Study of EVO756 in Adults With Migraine

   This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

   Stage

   Phase 2

   Ages

   18 to 64

   Site

   FutureSearch Trials of Neurology, Austin, Texas

   Locations

   35 in total

   Run by

   Evommune, Inc.

   See if you can join NCT07616128 on ClinicalTrials.gov

5. Responding With Evidence and Access for Childhood Headaches

   This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for yo…

   Stage

   Not phased

   Ages

   10 to 17

   Site

   Dell Children's Hospital-UT Health, Austin, Texas

   Locations

   15 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT05889624 on ClinicalTrials.gov

6. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

   Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin, Texas

   Locations

   129 in total

   Run by

   AbbVie

   See if you can join NCT05125302 on ClinicalTrials.gov